Emily shares the intense experience of navigating data collection during the pandemic, highlighting the dedication of public health officials. She discusses the emotional turmoil researchers face when results contradict their hypotheses, emphasizing the importance of scientific rigor even when the findings are not what one hopes for. The conversation also touches on the significance of reporting both safe and concerning signals in drug safety research.
